Pressure Intensifies to Lower Drug Prices

Source: Medscape

The price of ophthalmic drugs varies widely in the United States, and this can adversely affect patient care, data from a new study show, according to a report in Medscape.

“Our patients are the ones who are suffering because they show up at the pharmacy and they don’t know if they’re paying $10 or $200,” said Dan Gong, MD, from Columbia University Medical Center in New York City.

And prices are generally much higher in the United States than in other developed countries, he reported here at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting.

Read the full article.

Related Content